ArticleBone marrow transplantation2016

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation.

P Tsirigotis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.